PERC-Peds规则在美国儿童床旁无辐射排除肺栓塞(BEEPER):多中心前瞻性观察性诊断准确性研究
这项多中心、前瞻性、观察性诊断准确性研究在美国21个儿科急诊科纳入4–17岁因症状促使急诊医师开具或强烈考虑开具肺栓塞诊断检查的连续儿童,共4039例入组、4011例裁定。主要终点为PERC-Peds安全排除,定义为假阴性率95%CI上限不超过1.5%。裁定人群中位年龄15岁(IQR 13–16),女性2567例(64.0%)、男性1444例(36.0%);3988例数据完整,253例(6.3%,95%CI 5.6–7.2)在45天内诊断肺栓塞或近端深静脉血栓。PERC-Peds敏感度99.6%(95%CI 97.8–100.0),特异度19.6%(18.4–20.9),假阴性率0.1%(0.0–0.8)。
要点
- 在4–17岁疑似肺栓塞儿童中,PERC-Peds阴性规则假阴性率0.1%(95%CI 0.0–0.8),95%CI上限未超过预设的1.5%,达到安全排除的主要终点。
- 裁定人群中肺栓塞或近端深静脉血栓的45天发生率为6.3%(95%CI 5.6–7.2,253/3988)。
- PERC-Peds敏感度99.6%(95%CI 97.8–100.0),特异度19.6%(18.4–20.9)。
- 4011例中3161例(78.8%)开具了D-二聚体检测;PERC-Peds序贯D-二聚体在2167例(54.3%)中排除肺栓塞或近端深静脉血栓,假阴性率0.9%(95%CI 0.6–1.4)。
- 作者认为,使用PERC-Peds可能减少儿童和青少年肺栓塞的低价值诊断检查。
适用人群与场景
- 美国21个儿科急诊科中,年龄4–17岁、因症状促使急诊医师开具或强烈考虑开具肺栓塞诊断检查的儿童,为连续入组系列。
- 诊断检查包括D-二聚体检测,由临床医师自行决定。
诊断标准与关键阈值
- 主要终点为PERC-Peds安全排除,定义为假阴性率95%CI上限不超过1.5%。
- 肺栓塞的参考标准为45天内任何静脉血栓栓塞症结局,包括影像证实的肺栓塞或近端深静脉血栓(膝或肘以上,不包括孤立性隐静脉、肱静脉或小腿静脉血栓),由三名委员会认证的儿科急诊医师组成的独立委员会裁定。
研究设计与关键结果
- 多中心、前瞻性、观察性诊断准确性研究,2020年7月29日至2024年9月29日入组4039例儿童,4011例被裁定肺栓塞或近端深静脉血栓,末次随访日期为2025年9月18日。
- 裁定人群中位年龄15岁(IQR 13–16);女性2567例(64.0%),男性1444例(36.0%);3988例数据完整,253例(6.3%,95%CI 5.6–7.2)在45天内诊断肺栓塞或近端深静脉血栓。
- PERC-Peds敏感度99.6%(95%CI 97.8–100.0),特异度19.6%(95%CI 18.4–20.9),假阴性率0.1%(95%CI 0.0–0.8)。
- 4011例中3161例(78.8%)开具D-二聚体检测;PERC-Peds序贯D-二聚体在2167例(54.3%)中排除肺栓塞或近端深静脉血栓,假阴性率0.9%(95%CI 0.6–1.4)。
证据类型、等级与局限
- 证据类型:多中心、前瞻性、观察性诊断准确性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在疑似肺栓塞的儿童和青少年中,PERC-Peds阴性规则可安全排除肺栓塞,使用PERC-Peds可能减少低价值诊断检查。
- PERC-Peds序贯D-二聚体在54.3%的参与者中排除肺栓塞或近端深静脉血栓,假阴性率0.9%(95%CI 0.6–1.4)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In emergency care, clinicians currently have scarce evidence-based guidance on whether to order diagnostic tests for suspected pulmonary embolism in children. We aimed to test whether the Pulmonary Embolism Rule-Out Criteria in Children (PERC-Peds) can safely rule out pulmonary embolism in children.
METHODS: This multicentre, prospective, observational, diagnostic accuracy study was done in 21 paediatric emergency departments across the USA. We enrolled children aged 4-17 years who presented with symptoms prompting the emergency physician to order, or strongly consider ordering, a diagnostic test for pulmonary embolism. Participants formed a consecutive series. At the point of care, clinicians completed a case report form to record the components of the PERC-Peds rule. Diagnostic testing, including D-dimer testing, was done at clinician discretion. Trained research personnel collected patient-reported demographic data, symptoms, medications, and past medical histories prospectively and cross-checked patient-reported past medical histories and medications against data in the electronic health record. Follow-up was done 45 days after enrolment with a standardised, automated SMS message to caregivers. The criterion standard for pulmonary embolism was the outcome of any venous thromboembolism (VTE; including image-proven pulmonary embolism or proximal deep vein thrombosis [DVT; above knee or elbow, but not including isolated saphenous, brachial, or calf vein clots]) within 45 days, as adjudicated by an independent committee of three board-certified paediatric emergency physicians. Adjudicators viewed all imaging reports, information from the 45-day follow-up, and outside medical records. The primary endpoint was safe exclusion by use of PERC-Peds in all participants who were adjudicated, defined as the upper limit of the 95% CI for the false-negative rate not crossing 1·5%.
FINDINGS: Between July 29, 2020, and Sept 29, 2024, 4039 children were enrolled, with 4011 participants adjudicated for pulmonary embolism or proximal DVT. Date of last follow-up was Sept 18, 2025. The median age of the adjudicated population was 15 years (IQR 13-16); 2567 (64·0%) were female and 1444 (36·0%) were male. 3988 participants had complete data, and 253 (6·3%, 95% CI 5·6-7·2) were diagnosed with pulmonary embolism or proximal DVT within 45 days. The sensitivity of the PERC-Peds rule was 99·6% (95% CI 97·8-100·0), specificity was 19·6% (18·4-20·9), and false-negative rate was 0·1% (0·0-0·8). D-dimer test was ordered in 3161 (78·8%) of 4011 participants. Sequential use of PERC-Peds followed by D-dimer test ruled out pulmonary embolism or proximal DVT in 2167 (54·3%) with a false-negative rate of 0·9% (0·6-1·4).
INTERPRETATION: In this multicentre, prospective, observational, diagnostic accuracy study of children with suspected pulmonary embolism in the emergency department, we found a 6·3% prevalence of pulmonary embolism or proximal DVT; in this population, the PERC-Peds negative rule can safely rule out pulmonary embolism. Use of PERC-Peds might reduce low-value diagnostic testing for pulmonary embolism in children and adolescents.
FUNDING: US National Institutes of Health.
参考来源
- Ellison AM, Kuppermann N, Shihabuddin BS, et al. PERC-Peds rule for bedside exclusion of pulmonary embolism without radiation in children in the USA (BEEPER): a multicentre, prospective, observational, diagnostic accuracy study. Lancet Respir Med. 2026. PMID: 42398511. doi:10.1016/S2213-2600(26)00086-X
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。